Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.
about
Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI StudiesEpilepsy and attention-deficit hyperactivity disorder: links, risks, and challengesProfile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorderClinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsThe pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.Could vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia?Desynchronization of Theta-Phase Gamma-Amplitude Coupling during a Mental Arithmetic Task in Children with Attention Deficit/Hyperactivity Disorder.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.Considerations for ADHD in the child with epilepsy and the child with migraine.Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison.Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.
P2860
Q26744718-A1318E9C-29EF-40F8-8360-DA585444660EQ26765320-05DF99C9-4CBE-4403-BE3C-724A6AB9275FQ27692647-C18D151A-E591-48B1-8CD6-6DFA5C8CA579Q28265059-F6FAF911-2E92-42D6-A3B1-09D02638426BQ33165620-4DB0E7A9-BADE-4CB4-B014-CF38F0DEF08DQ35211484-CE8C9DA7-F8B7-4791-BC59-5B4B21E03141Q35940810-C76E8EC3-A782-4F5A-9AAA-025289C228B5Q36446854-FEE90698-F237-4D9A-80A7-C6B34472A5ACQ37722786-50E28E7B-04D9-4D8A-AFB9-D741C623D780Q38387691-45BD56C0-E1D2-4FAD-BC24-1D86CBEEBBA4Q38537323-2DD2A82D-784E-4516-BA08-5CBE7D7739D4Q38658017-43C2730F-58E5-4D0A-9F04-1FC92E2455FEQ38930427-8D44F036-74E9-4406-B593-5640F74FD0A4Q39154027-61D668ED-CD09-4950-AF87-90E33889AF7BQ47677209-06D55E4E-48EB-4A7C-AFAD-ACCE9D2A5015
P2860
Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Guanfacine for attention defic ...... atic review and meta-analysis.
@en
type
label
Guanfacine for attention defic ...... atic review and meta-analysis.
@en
prefLabel
Guanfacine for attention defic ...... atic review and meta-analysis.
@en
P2093
P50
P1476
Guanfacine for attention defic ...... atic review and meta-analysis.
@en
P2093
Francesco Rossi
Maurizio Bonati
Simona Ruggiero
P304
P356
10.1016/J.EURONEURO.2014.08.001
P407
P577
2014-08-11T00:00:00Z